Approval · Notice of Compliance 2151 · 2001
INTAL SYNCRONER: Notice of Compliance 2151
Issued January 5, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2151
- Date
- January 5, 2001
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Prophylaxis of symptoms of bronchial asthma
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTAL SYNCRONER | 00638641 | Cancelled Post Market |
| INTAL INHALER | 00555649 | Cancelled Post Market |
Medicinal ingredients
- CROMOLYN SODIUM 1 MG per ACT